# University College London

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/university-college-london
Canonical HTML page: https://getyourbrief.com/entity/university-college-london

## Timeline

- **2030**: Regulatory Review — Target window for potential FDA/EMA orphan drug or breakthrough device designation filing.
- **2028**: Commercial Scalability Assessment — Evaluation of bio-foundry partnerships to standardize the production of engineered scaffolds.
- **2027**: Regulatory Submission — Expected filing for Advanced Therapy Medicinal Product (ATMP) designation with the MHRA.
- **2027**: Expanded Trials — Anticipated commencement of multi-center trials for broader pediatric applications.
- **2026-Q4**: Expanded Clinical Trials — Anticipated start of Phase II trials involving a larger cohort of pediatric patients with long-gap OA.
- **2026-Q4**: Phase I Clinical Data — Expected release of initial safety data from first-in-human pilot studies.
- **2026-03-20**: Breakthrough Announcement — First successful lab-grown oesophagus for pediatric use is unveiled to the public.
- **2026-03-20**: Breakthrough Announced — First successful development of a lab-grown oesophagus for pediatric use is reported.

## Recent coverage (6 stories, network-wide)

### Ozen's £10 toothpaste bets on 30-year patent gap
2026-08-12 22:04:16 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Ozen enters the sensitive-toothpaste category at a £10 premium price, armed with a novel aerogel formulation and the claimed first sensitivity patent in nearly 30 years. The launch targets a mass-market whitespace long dominated by weeks-long desensitizing formulations.
Full story: https://getretailbrief.com/story/ozen-10-pound-toothpaste-sensitivity-retail

### £10 aerogel toothpaste claims instant end to tooth sensitivity
2026-08-12 22:04:07 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Full story: https://gethealthbrief.com/story/ozen-aerogel-toothpaste-instant-sensitivity-health

### 75% of U.S. Scientists Consider Leaving; UK Recruits 3 Elite Experts
2026-08-01 19:43:07 · Sector: hr · Sentiment: Neutral · Impact: 5/10 · Sources: 5

HR leaders face a talent crisis as prominent researchers Megan Peters, Tamara Swaab, and Ron Mangun opt for U.K. positions, reflecting a wider trend: 75% of surveyed scientists are considering leaving the U.S. The shift demands proactive workforce retention strategies.
Full story: https://gethrbrief.com/story/scientist-exodus-talent-hr-uk

### 33% Spike in U.S. Scientists Seeking Jobs Abroad Hits Biotech R&D Pipeline
2026-08-01 19:42:55 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 5

Biotech and pharma firms face a growing brain drain as three top U.S. cognitive scientists relocate to the U.K. amid NIH and NSF funding upheavals. A survey shows 75% of scientists are considering leaving, threatening the talent pipeline for drug discovery and clinical research.
Full story: https://getbiobrief.com/story/brain-drain-biotech-scientists-uk-trump

### First Lab-Grown Oesophagus Breakthrough Offers Hope for Rare Pediatric Conditions
2026-03-20 12:12:56 · Sector: bio · Sentiment: Strongly positive · Impact: 8/10 · Sources: 3

A groundbreaking medical milestone has been achieved with the development of the first lab-grown oesophagus, offering a transformative treatment for children born with rare congenital conditions. This regenerative medicine breakthrough uses tissue engineering to create functional organs, potentially replacing invasive surgeries that currently rely on repositioning other digestive organs.
Full story: https://getbiobrief.com/story/lab-grown-oesophagus-breakthrough-pediatric-surgery

### First Lab-Grown Oesophagus Offers Hope for Children with Rare Conditions
2026-03-20 12:11:22 · Sector: health · Sentiment: Strongly positive · Impact: 8/10 · Sources: 3

Researchers have successfully engineered the first lab-grown oesophagus, providing a transformative solution for children born with Oesophageal Atresia. This tissue-engineered breakthrough uses a patient's own cells to create a functional organ, potentially eliminating the need for high-risk invasive surgeries.
Full story: https://gethealthbrief.com/story/lab-grown-oesophagus-pediatric-breakthrough

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.